Want to move your work from bench to bedside as seamlessly as possible? Check out the Clinical and Translational Science Award (CTSA) program’s Trial Innovation Network (TIN).
TIN is a new CTSA collaborative initiative that congregates the expertise and resources from CTSA program hubs to help innovate your study. TIN includes features like a central IRB system, webinars, study design toolkits, and more to make your study more effective.
TIN also offers support for efficacy to effectiveness (E2E) trials, or trials where a successful efficacy study transitions seamlessly into an effectiveness trial. Studies like these are important because they address safety gaps, streamline the trial process, and offer an opportunity to better understand how a treatment will work in real-world clinical settings.
Learn how to boost your trial design at the two-day E2E Design Lab workshop March 7-8 in Boston, MA, offered by CTSA’s Massachusetts Institute of Technology (MIT) NEWDIGS program in collaboration with the JHU-Tufts Trial Innovation Center. The interactive event will dive into the process of planning a Phase 2 or Phase 3 E2E multi-center trial to help you improve your research and study design.
You can also take advantage of JHU-Tufts Trial Innovation Center’s E2E consultations. Receive personalized advice and trial design support from the center to help transition your efficacy trial quickly and efficiently. From protocol-specific consultations to statistical analysis advice, TIN resources can help you innovate your work as it moves through the phases of testing.
TIN’s trial support services are open to all of ITM 2.0, including UChicago, Rush, NorthShore, IIT Advocate, and Loyola.
About the Institute for Translational Medicine (ITM)
The Institute for Translational Medicine (ITM), a partnership between the University of Chicago and Rush in collaboration with several health and research institutions, helps make scientific discoveries possible and speeds up the time it takes to convert that research into real-world applications that improve people’s health.
The ITM works with more than 60 institutions across the country as part of the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) consortium to advance medicine in innovative ways.
During the last 10 years, the ITM has connected more than 2,000 researchers and community organizations with funding, training, and other resources while forging connections across departments, universities, and patient advocacy groups. The ITM includes four key affiliates, Advocate Health Care, the Illinois Institute of Technology (IIT), Loyola University of Chicago, and NorthShore University HealthSystem. Since its 2007 inception, total funding for the ITM has exceeded $60 million through the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) and through the University of Chicago Medicine and Biological Sciences.
Visit us at itm.uchicago.edu to learn more, and follow us on Facebook and Twitter @UChicagoITM to join our virtual community.